Literature DB >> 20887211

Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas.

Mohamed G Shoreibah1, Crystal L Jackson, Paul W Price, Richard Meagher, Andrew K Godwin, Qi Cai, Jeffrey C Gildersleeve.   

Abstract

Hesca-2, a monoclonal antibody (mAb) IgM raised to the human embryonic stem cell (hESC) line BG-01v, binds with high affinity (nM) to the disaccharide epitope (Galβ1-3GlcNAc) on a glycan microarray. This epitope was expressed on pluripotent progenitor hESCs in culture, but not in various differentiated cells derived from hESC based on immunofluorescence microscopy. Hesca-2 stains a limited subset of cells in adult human tissues (eg, esophagus and breast). This mAb also crossreacts in immunofluorescence microscopy studies with several human ovarian cancer cell lines and is cytotoxic to them based on the release of cytosolic enzyme lactate dehydrogenase into the media. Hesca-2 immunohistochemically stained tissue from a number of human tumors, including ovary, breast, colon, and esophageal cancer. These data suggest that Hesca-2 recognizes a surface marker found both in stem cells and certain cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887211      PMCID: PMC3128762          DOI: 10.1089/scd.2010.0172

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  57 in total

1.  Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.

Authors:  S A Przyborski
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

Review 2.  Characterization and differentiation of human embryonic stem cells.

Authors:  M K Carpenter; E Rosler; M S Rao
Journal:  Cloning Stem Cells       Date:  2003

Review 3.  Glycan arrays: recent advances and future challenges.

Authors:  Oyindasola Oyelaran; Jeffrey C Gildersleeve
Journal:  Curr Opin Chem Biol       Date:  2009-07-20       Impact factor: 8.822

4.  Profiling human serum antibodies with a carbohydrate antigen microarray.

Authors:  Oyindasola Oyelaran; Lisa M McShane; Lori Dodd; Jeffrey C Gildersleeve
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

5.  Interaction of galectin-1 with caveolae induces mouse embryonic stem cell proliferation through the Src, ERas, Akt and mTOR signaling pathways.

Authors:  M Y Lee; S H Lee; J H Park; H J Han
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

Review 6.  Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

Authors:  Gabriel A Rabinovich; Marta A Toscano
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

7.  CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.

Authors:  Anjali P Kusumbe; Avinash M Mali; Sharmila A Bapat
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

8.  The RAV12 monoclonal antibody recognizes the N-linked glycotope RAAG12: expression in human normal and tumor tissues.

Authors:  Suzanne K Coberly; Francine Z Chen; Mark P Armanini; Yan Chen; Peter F Young; Jennie P Mather; Deryk T Loo
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

Review 9.  Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane.

Authors:  Patrick Lajoie; Jacky G Goetz; James W Dennis; Ivan R Nabi
Journal:  J Cell Biol       Date:  2009-04-27       Impact factor: 10.539

10.  CD133 antigen expression in ovarian cancer.

Authors:  Gabriella Ferrandina; Enrica Martinelli; Marco Petrillo; Maria Grazia Prisco; Gianfranco Zannoni; Stefano Sioletic; Giovanni Scambia
Journal:  BMC Cancer       Date:  2009-07-07       Impact factor: 4.430

View more
  6 in total

1.  Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.

Authors:  Eric Sterner; Megan L Peach; Marc C Nicklaus; Jeffrey C Gildersleeve
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

2.  Microarray-guided evaluation of the frequency, B-cell origins, and selectivity of human glycan-binding antibodies reveals new insights and novel antibodies.

Authors:  J Sebastian Temme; Jennifer A Crainic; Laura M Walker; Weizhun Yang; Zibin Tan; Xuefei Huang; Jeffrey C Gildersleeve
Journal:  J Biol Chem       Date:  2022-09-08       Impact factor: 5.486

3.  Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.

Authors:  Jeffrey C Gildersleeve; Baomei Wang; Samuel Achilefu; Zhude Tu; Mai Xu
Journal:  Bioorg Med Chem Lett       Date:  2012-09-24       Impact factor: 2.823

Review 4.  IgE-based immunotherapy of cancer: challenges and chances.

Authors:  J Singer; E Jensen-Jarolim
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

5.  Competition between serum IgG, IgM, and IgA anti-glycan antibodies.

Authors:  Saddam M Muthana; Li Xia; Christopher T Campbell; Yalong Zhang; Jeffrey C Gildersleeve
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.

Authors:  Matthew Choo; Heng Liang Tan; Vanessa Ding; Roberto Castangia; Omar Belgacem; Brian Liau; Lauren Hartley-Tassell; Stuart M Haslam; Anne Dell; Andre Choo
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.